ArticleJournal of diabetes science and technology2022
Relationships Between Socioeconomic Status, Insurance Coverage for Diabetes Technology and Adverse Health in Patients With Type 1 Diabetes.
Article in Journal of diabetes science and technology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
27 citing papers in PubMed, 45 citations in OpenAlex.
- Identification of Different Age-at-Diagnosis-Based Endotypes and Clinical Phenotypes in a Cohort of Adult Patients Diagnosed with Type 1 Diabetes.Journal of clinical medicine · 2026Article
- Beyond access: Racial and socioeconomic disparities in device use among youth with type 1 diabetes.SSM. Qualitative research in health · 2026Article
- Factors Associated With Time to Automated Insulin Delivery System Initiation in Adults With Type 1 Diabetes on Multiple Daily Injections.Journal of diabetes science and technology · 2026Article
- Use of continuous glucose monitoring systems in pediatric patients in the perioperative environment: Challenges and machine learning opportunities.World journal of clinical pediatrics · 2025Review
- Association of Sex and Other Demographic Characteristics with Hemoglobin A1c in Older Adults with Type 1 Diabetes: Cross-sectional analysis of the U.S. Premier Healthcare Database.medRxiv : the preprint server for health sciences · 2025Article
- Disparities in access to and use of diabetes technologies and therapeutics: a narrative review.Diabetologia · 2025Review
- Article
- Article
- Association Between Food Insecurity and Inability to Obtain Provider-Recommended Medications, Multidisciplinary Services, and Technology in Youth and Young Adults With Diabetes: A Cross-Sectional Study.Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · 2025Article
- Impact of Continuous Glucose Monitoring Sourcing on Real-World Adherence and Health Care Costs: A Comparative Analysis by Insurance Type.Clinical diabetes : a publication of the American Diabetes Association · 2025Article
- Impact of Demographic Features on Glycemic Management With Tubeless Automated Insulin Delivery Systems in Youth With Type 1 Diabetes.Diabetes spectrum : a publication of the American Diabetes Association · 2025Article
- Investigating the Association Between Family Socioeconomic Profile and Diabetes Control in Children: A Cross-Sectional Study From Sudan.Endocrinology, diabetes & metabolism · 2025Article
- Public Health System Funding for isCGM Reduces Socioeconomic Disparities in Type 2 Diabetes Control: A Cohort Study.Journal of diabetes research · 2025Article
- Characterizing the relationship between social determinants of health and risk of albuminuria among children with type 1 diabetes.Journal of diabetes and its complications · 2024Article
- Health disparities in the risk of severe acidosis: real-world evidence from the All of Us cohort.Journal of the American Medical Informatics Association : JAMIA · 2024Article
- Impact of socioeconomic status on chronic control and complications of type 1 diabetes mellitus in users of glucose flash systems: a follow-up study.BMC medicine · 2024Article
- Increasing Continuous Glucose Monitoring Use for Non-Hispanic Black and Hispanic People With Type 1 Diabetes: Results From the T1D Exchange Quality Improvement Collaborative Equity Study.Clinical diabetes : a publication of the American Diabetes Association · 2024Article
- Insulin Pump Utilization in 2017-2021 for More Than 22,000 Children and Adults With Type 1 Diabetes: A Multicenter Observational Study.Clinical diabetes : a publication of the American Diabetes Association · 2024Article
- The impact of socioeconomic factors, social determinants, and ethnicity on the utilization of glucose sensor technology among persons with diabetes mellitus: a narrative review.Therapeutic advances in endocrinology and metabolism · 2024Review
- The success of insulin pump therapy: importance of education of patients and health professionals.Frontiers in clinical diabetes and healthcare · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
Abstract
introductionInsulin pumps and continuous glucose monitors (CGM) have many benefits in the management of type 1 diabetes. Unfortunately disparities in technology access occur in groups with increased risk for adverse effects (eg, low socioeconomic status [SES], public insurance). RESEARCH DESIGN &
methodsUsing 2015 to 2016 data from 4,895 participants from the T1D Exchange Registry, a structural equation model (SEM) was fit to explore the hypothesized direct and indirect relationships between SES, insurance features, access to diabetes technology, and adverse clinical outcomes (diabetic ketoacidosis, hypoglycemia). SEM was estimated using the maximum likelihood method and standardized path coefficients are presented.
resultsHigher SES and more generous insurance coverage were directly associated with CGM use (β = 1.52, SE = 0.12,
conclusionsThe association between SES and insurance coverage and adverse outcomes was primarily mediated through diabetes technology use, suggesting that disparities in diabetes outcomes have the potential to be mitigated by addressing the upstream disparities in technology use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.